ELYSE HUFF: Open Payments
NPI 1093213688 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,775 in 109 payments from 32 companies in 2025. Trend: 2023 $2,926 · 2024 $2,634 · 2025 $2,775
Food & beverage: $2,691Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $737 |
| AstraZeneca Pharmaceuticals LP | 7 | $199 |
| PFIZER INC. | 13 | $197 |
| Merck Sharp & Dohme LLC | 7 | $140 |
| ARRAY BIOPHARMA INC | 1 | $135 |
| Incyte Corporation | 6 | $110 |
| Janssen Biotech, Inc. | 5 | $109 |
| BeOne Medicines USA, Inc. | 4 | $92 |
| Stemline Therapeutics Inc. | 3 | $85 |
| SEAGEN INC. | 1 | $84 |
Products named: LORBRENA, KEYTRUDA, JAKAFI, ENHERTU, BRUKINSA, Orserdu, NATRELLE SALINE-FILLED BREAST IMPLANTS, REBLOZYL.
Industry payments across FL — which companies pay providers there.
